GSK plcGSK

Is GSK cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$48.63+0.09 (+0.19%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$99B
Large-cap
+22%
2016 — today
10-Year Price
+17%
2016 — today
52-Week Range
$39.52$61.18
Current $48.63· 42%

GSK plc (formerly GlaxoSmithKline) researches, develops, and manufactures vaccines and specialty medicines globally. Organized into Commercial Operations and R&D, its portfolio includes immunizations for shingles, meningitis, RSV, and influenza, alongside treatments for HIV, oncology, respiratory conditions (asthma/COPD), and infections. Innovation is driven by strategic partnerships, including mRNA vaccine development with CureVac, oligonucleotide platforms with Wave Life Sciences, and research alliances for Parkinson’s and fibrotic diseases.

Similar companies

Healthcare companies of comparable size to GSK
CompanyP/EDiv yield
SNYSanofi75.15.7%
HCAHCA Healthcare, Inc.14.10.7%
MCKMcKesson Corporation23.90.4%
SYKStryker Corporation28.51.3%
ELVElevance Health Inc.17.61.7%
REGNRegeneron Pharmaceuticals, Inc.20.00.5%
MDTMedtronic plc22.63.1%
CVSCVS Health Corporation25.22.8%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
15.1
Around average
Around the 10-year average
Sector median 25.2below sector
P/B ratio
4.3
Around average
Around the 10-year average
Sector median 2.5above sector
EV / EBITDA
8.1
Near historic low
Near historic low — last 10 years
Sector median 15.4below sector
Dividend Yield
3.7%
Historically low
Historically low relative to the last 10 years
Sector median 1.8%above sector
PEG ratio
10.1
Near historic high
Near historic highs — last 10 years
Sector median 1.4above sector
FCF Yield
9.6%
Above average
Above the 10-year average
Sector median -9.6%above sector
Free · No credit card needed

Get alerted when GSK is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.